Allianz Asset Management GmbH - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$1,569,000
+46.2%
67,4590.0%0.00%
+100.0%
Q1 2018$1,073,000
-24.0%
67,4590.0%0.00%0.0%
Q4 2017$1,411,000
+259.9%
67,459
+150.3%
0.00%
Q4 2016$392,000
-68.5%
26,954
-46.6%
0.00%
-100.0%
Q3 2016$1,245,000
-52.1%
50,491
-61.0%
0.00%
-66.7%
Q2 2016$2,599,000
-55.7%
129,586
-26.2%
0.00%
-57.1%
Q1 2016$5,864,000
-76.5%
175,577
-3.3%
0.01%
-75.0%
Q4 2015$24,959,000
-25.4%
181,585
+26.9%
0.03%
-30.0%
Q3 2015$33,447,000
-52.3%
143,146
-44.4%
0.04%
-46.7%
Q2 2015$70,118,000
+28.1%
257,236
-6.6%
0.08%
+21.0%
Q1 2015$54,727,000
+58.8%
275,538
+14.4%
0.06%
+63.2%
Q4 2014$34,454,000
-48.7%
240,754
-52.9%
0.04%
-53.1%
Q3 2014$67,125,000
+2.0%
511,623
-1.9%
0.08%
-2.4%
Q2 2014$65,777,000
+7.6%
521,542
+12.4%
0.08%
+13.7%
Q1 2014$61,145,000
+26.2%
463,816
+12.4%
0.07%
+17.7%
Q4 2013$48,452,000
+211.3%
412,713
+176.7%
0.06%
+195.2%
Q3 2013$15,563,000
+57.7%
149,167
+30.1%
0.02%
+50.0%
Q2 2013$9,867,000114,6340.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2017
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders